Efficacy and tolerability of lurasidone in schizophrenia: A systematic review and meta-analysis of short-term, randomized, placebo controlled trials

INTRODUCTION: Lurasidone is an atypical antipsychotic approved for the treatment of patients with schizophrenia. We report on a meta-analysis focusing on both the efficacy and safety/tolerability of lurasidone in the treatment of patients with schizophrenia. OBJECTIVES: To obtain pooled estimates fr...

Descripción completa

Detalles Bibliográficos
Autores principales: Hagi, K., Nosaka, T., Kane, J., Correll, C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2021
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9471728/
http://dx.doi.org/10.1192/j.eurpsy.2021.424

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9471728/
http://dx.doi.org/10.1192/j.eurpsy.2021.424

Ejemplares similares